Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFARELIN for Controlled ovarian stimulation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where NAFARELIN was used for Controlled ovarian stimulation.

Most Reported Side Effects for NAFARELIN

Side Effect Reports % Deaths Hosp.
Ovarian hyperstimulation syndrome 50 23.9% 0 41
Dyspnoea 19 9.1% 0 14
Ascites 16 7.7% 0 15
Off label use 14 6.7% 0 7
Diarrhoea 13 6.2% 0 2
Abdominal pain lower 12 5.7% 0 12
Nausea 12 5.7% 0 6
Condition aggravated 11 5.3% 1 5
Abdominal pain 10 4.8% 0 7
Headache 9 4.3% 0 0
Muscle twitching 9 4.3% 0 1
Pain 9 4.3% 0 6
Dysgeusia 8 3.8% 0 0
Ovarian cyst ruptured 8 3.8% 0 7
Abdominal distension 7 3.4% 0 6

Other Indications for NAFARELIN

Assisted reproductive technology (42) In vitro fertilisation (35) Endometriosis (34) Assisted fertilisation (15) Product used for unknown indication (8) Management of reproduction (5)

Other Drugs Used for Controlled ovarian stimulation

FOLLITROPIN (122) GANIRELIX (87) CHORIOGONADOTROPIN ALFA (75) TRIPTORELIN (41) CETRORELIX (37) FOLLITROPIN\LUTEINIZING HORMONE (33) MENOTROPINS (29) FOLLITROPIN ALFA (24) LETROZOLE (24) FOLLITROPIN BETA (21)

Related Pages

NAFARELIN Full Profile All Controlled ovarian stimulation Drugs NAFARELIN Demographics NAFARELIN Timeline